chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from a pharmacist concerning a patient who in approximately January 2010, "within the last week or within the last 30 days", was vaccinated with PNEUMOVAX 23 (lot # 663936/0508Y) through subcutaneous injection (dose and site not reported). In approximately January 2010, "within the last week or within the last 30 days", the patient experienced injection site reaction soon after. The patient was in the hospital before receiving the vaccine and hospitalization was not due to vaccination. The outcome of injection site reaction was not reported. This is one of the several reports from the same source. All telephone attempts to obtain follow-up information have been unsuccessful. A standard lot check investigation has been finalized. All in-process quality checks for the lot number 663936/0508Y were satisfactory. The lot met the requirements of the Center for Biologics Evaluation and Research and was released. Additional information has been requested.
Shooting pains from left leg down to toes; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Shooting pains from left leg down to toes) in a 35-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 020S21A) for COVID-19 vaccination.     No Medical History information was reported.    On 29-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Aug-2021, the patient experienced PAIN (Shooting pains from left leg down to toes). At the time of the report, PAIN (Shooting pains from left leg down to toes) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Received MMR 2/10/03 with no symptoms until 2/22/03 noticed tenderness with nodule at injection on 2/23/03. Palpable tender mass 25 mm x 35 mm. No erythema.
severe anaphylactic shock; High blood pressure; This is a spontaneous report from a contactable consumer (patient). An 84-year-old female patient received the second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration, administered in left arm on 23Feb2021 09:30 (Lot Number: EN6200) as single dose for covid-19 immunisation at age 84 years old. Medical history included low thyroid and allergies to grasses. The patient was not pregnant. The patient had no Covid prior to vaccination and was not Covid tested post vaccination. Concomitant medications included levothyroxine sodium (SYNTHROID) taken for an unspecified indication, start and stop date were not reported. No other vaccine taken in four weeks. The patient previously received the first dose of BNT162B2 administered in left arm on 02Feb2021 09:30 AM (lot no: EC9265) for COVID-19 immunization. On 16Mar2021 09:15 AM, 15 minutes after eating usual breakfast: avocado/toast, coffee, almond milk, the patient went into severe anaphylactic shock: extreme itching on palms, red welts on body, explosive diarrhea, dizzy/fainted, extreme blood pressure drop to 60/XX, in/out of consciousnes, loss of bowel/urine. Rushed to ER. High blood pressure 7 days after (Mar2021). The events resulted in Doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care, emergency room/department or urgent care and were considered life threatening illness (immediate risk of death from the event). Treatment given in the emergency room includes unknown (as reported), prednisone, Pepcid. Outcome of the event was unknown.
Initially I had the typical chills, fever, fatigue, headache  and sore arm. I have continued to experience headaches fairly persistently since the second vaccine along with a stiff/sore neck.  It has been over a month and am finding this quite unpleasant.  Limits my activity
After a week, I had perineal pain, bladder discomfort. got better in 2 days.   ITCHING, UTRICARIA, patches of red  itchy rash,  with dermographism.  itchy skin generalized.  started 11-12 days after he vaccine.  have to take Allegra to get relief and to suppress it from coming. Without Allegra it causes itchy rash and  burning and hot patches  multiple areas of utricaria.   I am a physician and i never had any side effects after a vaccine so far. I kept waiting it will abate, but it keeps coming back without Allegra. its frustrating.
quarter sized raised, warm, red mark that was itchy for 2 days.   Baby due date is 11/20/19
Immediate dizziness. Rapid heart beat. Warmth. Sensitivity to light. Discomfort in throat and upper abdomen. Chest tightness. Heaviness in head and eyes. Monitored for 2 hours in clinic. Fatigue, intermittent chest pain and persistent discomfort in head, eyes and abdomin are ongoing now, over 48 hours later.
ThPatient had some discomfort in the stomach prior the administration of 2nd dose of vaccine. On 16-FEB-2021, Patient developed nausea after the administration of second dose of vaccine .e patient's medical history was not provided. No relevant concomitant medications were reported   The patient received both scheduled doses of mRNA-1273 prior to the event(s); therefore, action taken with the drug in response to the event(s) is not applicable.  The outcoms of events were not reported.
Patient is underage and not eligible for Moderna. She is 14 yrs old and must be 18+.
pt recv flu vax & pneumococcal vax combined & given in one inj & exp cellulitis to elbow, fever, site warm, pain;DPH, ATB per MD;
Pt was given Pfizer Bivalent dose of 0.5 ml.  Given her age, she should have been given 0.2 ml
On my second dose of the vaccine I began having severe flank pain at 3am (ten hours post vaccine). My pain levels increased to an 8/10. I got a fever by 6pm Monday and by 10pm Monday my fever spiked to 103.7. I threw up, had to take an ambulance to the hospital and couldn?t move on my own. My lymph nodes swelled in my left arm. I also have burst capillaries all over my body.  Im on day four of post vaccine and still can?t eat without vomiting, have severe weakness and joint pain.
Initial report received from a healthcare professional on 31 July 2013. A 25-year old female patient, whose medical history and concomitant medications were not reported, had received first intramuscular dose of ADACEL vaccine (batch number: U4586AA, and site of administration was not reported) on 30 July 2013. The patient was pregnant at the time of vaccination. The patient's last menstrual period date was 15 April 2013. The estimated date of delivery was reported as 26 September 2013. Patient's health during pregnancy and risk factors were reported as "N/A". At the time of the report, the patient had not experienced any adverse events. Documents held by sender: none.
The vaccine was given on campus on the 26th of January 2005. The next day client experienced hives she took Benadryl for this. On Friday 28th she woke up with swollen hands and went to the campus health office. She was later seen by the family physican. He prescribed Prednisone. On the 29th she awoke with swollen hands and feet and hives and pain and discomfort and nausea & later the evening experienced swollen lips. The swelling did subside by the 30th of January however she is still experiencing hives over most of her body. She is still using Benadryl and Prednisone.
On date of vaccine, she developed severe site pain and has been ongoing. A week later she is experiencing swollen, hot, hard and painful arm at the injection site, rash on back of her neck. Unable to touch armpit-very painful, has chills, but has not taken temp.  Not taken anything for sxs
seasonal allergies; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program (159558). The reporter is the patient.  A female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2, for covid-19 immunization. The following information was reported: SEASONAL ALLERGY (non-serious), outcome "unknown", described as "seasonal allergies". Therapeutic measures were taken as a result of seasonal allergy.  Additional information: Caller (name) called in today and said Yesterday morning she received the 2nd dose of Covid-19 Vaccine. But then she was experiencing seasonal allergies and because of that she took Dayquil Medicine that has a tylenol in it. She wanted to know if that was okay or if that medicine will interfere with Covid-19 Vaccine.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
2nd day arm pain started lasted 8 days. 2nd day bruise, currently have bruise it's the 12th day. Bruise larger than half dollar.  Left shoulder pain has lessened but still ongoing. Body gets very hot, sometimes followed by immediate chills started day 3 and continues currently (12 day today)
No adverse event; 47 patients received the Moderna Covid-19 bivalent vaccine after the use-by date.; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (47 patients received the Moderna Covid-19 bivalent vaccine after the use-by date.) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7642B) for COVID-19 prophylaxis.     No Medical History information was reported.    On 26-Jun-2023, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 26-Jun-2023, the patient experienced EXPIRED PRODUCT ADMINISTERED (47 patients received the Moderna Covid-19 bivalent vaccine after the use-by date.). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (47 patients received the Moderna Covid-19 bivalent vaccine after the use-by date.) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (47 patients received the Moderna Covid-19 bivalent vaccine after the use-by date.).    Patient was over 18 years of age. No relevant concomitant medications were reported. Staff gave patients vaccines past the use date of 18 Jun 2023. On 26 Jun 2023, 2 doses were administered at administration site 2. No treatment medication reported.   This case was for the 32nd patient out of 47 reported.   This case was linked to US-MODERNATX, INC.-MOD-2023-732752 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 07-Jul-2023: Live Follow-up received contains Vaccine information reported and narrative updated.; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-732752:Master case (Patient 01)
Information has been received from a physician concerning 2 pts who were vaccinated with varicella virus vaccine live (dosage, dose series, route and lot number not provided). The physician reported that she has seen 2 pts develop "zoster" and inquired as to how common it was to observe this condition in pts who have received vaccination with varicella virus vaccine live. Additional information has been requested.
Patient stated this was her 1st moderna dose and she is 10 weeks pregnant.  She said she got the shot on 10/18 and only had the usualy sore arm right after but on 10/24 around 3pm, she reported a sore arm, redness of a big circle, knot under the skin and pain.  She is worried about getting the second dose if she is having these delayed symptoms after the first one.
Administration of an expired vaccine; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administration of an expired vaccine) in a 73-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administration of an expired vaccine). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Administration of an expired vaccine) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were provided.  No treatment medications were provided.   This case was linked to MOD-2021-369083 (Patient Link).
At 6pm my teeth started hurting again just like they were after the first shot (I was just starting to recover from the first shot). I was going through the act same situation for a second time. Unable to chew and or brush my teeth. Aside from the teeth discomfort I was felt fine. The next day I woke up to fever, chills and body aches that lasted for 8 hours. I was extremely tired and felt weak. This tiredness lasted for an entire month. The mouth discomfit and pain lasted for another 5-6 weeks after the shot. Medication-Clove oil every hour for a total of 4 weeks
On 11/17/2019 Started coughing,  runny nose and itching, and red rashes on face, back, and legs.
Information has been received from a medical assistant and an office manager referring to a patient of unknown age and gender. Information about concurrent condition, concomitant medication and medical history were not provided. On an unspecified date, a dose of improperly stored PROQUAD (lot # L051102, exp date 17-JUN-2016) (dose, frequency and route was not provided) had undergone 2 excursions was administered to an unknown patient. The vaccine was stored at 6.5 degree C for 7 hours and 45 minutes and at 4.9 degree C for 4 hours and 45 minutes. Digital data logger was involved. No adverse effect was reported. Additional information has been requested.
Left arm paralysis, weakness, loss of motor control, unable to abduct arm, pain and tenderness on palpation, notable marble sized deposit in muscle belly, lasted 2 months constantly then went to intermittently.
Vomiting/nausea 1 day after vaccines. Treated with ZOFRAN and clear fluids. Redness/tenderness/ swelling at site of Varicella vaccine.
After receiving the Pfizer Covid vaccine at 11:43 AM, we had a patient alert one of the technicians (at 11:50 AM)that he wasn't feeling well. He said that he felt a little dizzy and hot and started to feel nauseous. The pharmacist gave him a cold compress and had him lie on the ground and elevate his feet. After about 10 minutes the patient said he felt fine so we helped him back in his chair and asked that he stay longer for us to monitor him. He waiting an additional 15 minutes and said he felt fine and left.
Upon receiving vaccine I immediately had severe arm pain.  The injection itself was extremely painful and immediately afterwards pain worsened from elbow to top of shoulder and has not let up.  I have zero mobility and the severe pain is not responding to over the counter pain relief medicine.
COVID Breakthrough. Patient presented to the Emergency Dept on 4/1 with cough and shoulder pain. She states she tested positive for COVID 5 days prior.
Sore arm after receiving a Shingrix shot; This case was reported by a consumer and described the occurrence of injection site pain in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced injection site pain. On an unknown date, the outcome of the injection site pain was recovered/resolved.   The reporter considered the injection site pain to be related to Shingrix.  Additional details were provided as follows: The reporter was friend.  The age at vaccination was not reported. The patient was in her 60's and had complained about having a sore arm (at injection site) after receiving a Shingrix shot. No further information was gathered such as the patient's initials or whether it was dose 1 or dose 2(or both).  The reporter also stated that patient did not experience a fever after receiving the Shingrix shot. This is 1 of 5 linked cases, reported by same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021013457:Same reporter. US-GLAXOSMITHKLINE-US2021AMR014254:Same reporter. US-GLAXOSMITHKLINE-US2021AMR014253:Same reporter. US-GLAXOSMITHKLINE-US2021AMR014110:Same reporter.
c/o swelling of rt eye 3 days p/vax;DPh given;worse by next day & rt side of face neck & shoulder felt numb & tingling;went to ER;took more DPH & slept;resolved in 2 days;
Non-specific non-injection-site rash at small sites on two arms and one leg. Rash resolved within a few days.
high blood pressure; This is a spontaneous report from a Pfizer sponsored Program. A contactable female patient of unspecified age received BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), (Lot number& Expiry date not reported) via unspecified route of administration on unspecified date as dose 1, single for COVID-19 immunization. Patient medical history and concomitant medications were not reported. Caller wanted to know if it is okay for her to take the second dose, due tomorrow while she is having high blood pressure and took medications for it on unspecified date. Treatment was received by patient for hypertension. Patient underwent lab test and procedures include blood pressure measurement result include high. The outcome of event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Dehydration over 3- 4 weeks plus delay in menstrual cycle by 10 days so far- hospital Administered pregnancy test is negative.   Hormones do not indicate menopause stage.  Previous period was 4/22/2021-
Hives and hoarseness. Took 25 mg Benadryl po.
This spontaneous reporter was received from a consumer regarding herself a 59 year old female patient. The patient's pertinent medical history included shingles years ago from which she recovered. Patient had no drug allergies or reactions. On 12-JAN-2016, the patient was vaccinated with ZOSTAVAX, 19400 PFU(DF), 0.65 ML, subcutaneous. Patient was on none concomitant medication. On 15-JAN-2016, the patient in the morning woke up with an itching at the injection site. Later in the day it became red, achy, hot, hard and swollen. The patient spoke with her pharmacist who gave her hydrocortisone to treat the AE. No laboratory studies were performed. Patient spoke to pharmacist to seek medical attention. The outcome of itching at the injection site and it became red, achy, hot, hard and swollen was reported as not resolved as reported she was still experiencing the AE. Causality between itching at the injection site and it became red, achy, hot, hard and swollen and ZOSTAVAX was unknown. Additional information has been requested.
Left arm injection site soreness started about 4 hours after administration. Left full arm tingling lasted about 12 hours then resolved. Left arm soreness lasted for about 36-48 hours with some mild nasal congestion and shortness of breath.
The patient received their first of two planned doses of mRNA-1273 (lot number unknown) on an unknown date.  On 14 Feb 2021, prior to the onset of the event, the patient received their second of two planned doses of mRNA-1273 (lot number: 022M20A) for prophylaxis of COVID-19 infection.   When the patient received the second dose of the vaccine, the content of the vial was not milky white.  The vaccine was not drawn from a vial, but the syringe was already filled.  He stated the injection was like water, not white.  He also reported that looking at the syringe, he noticed he may have gotten more than the 0.5 ml recommended dose (he then changed his mind and said he thought he got the right dose).  Treatment information was not provided.  The patient received both scheduled doses of mRNA-1273 prior to the event; therefore, the action taken with the drug in response to the event was not applicable.  The event, content of the vial was not milky white/injection was like water, not white, was considered recovered/resolved on 14 Feb 2021.
The patient pre-medicated with oral diphenhydramine because she had an allergic reaction to another vaccine in the past. The patient developed some upper body redness and slight eyelid swelling, and she continued to treat with oral diphenhydramine until symptoms resolved.
Incident occurred at a COVID19 mass vaccination clinic. Within 5-10 minutes after vaccination, client complaint of dizziness, nausea, and right eye was twitching and drooping.  Client stated that they had a history of penicillin allergy with a hives/rash reaction. Client checked his sugar and it was at 138. EMS that was on-site checked vitals @11:22 BP 160/100 pulse 72 resp 16 pupils NTL , alert and verbal, skin normal, respirations normal; @11:33 BP 160/105. Client initially refusing transport by EMS. After 45 minutes of blood pressure not dropping, client agreed. @11:50 EMS transport by EMS. Hospital has attempted to reach client for follow up of outcome but has not received return call.
Diverticulitis inflammation months after second vaccine; This spontaneous case was reported by a consumer and describes the occurrence of DIVERTICULITIS (Diverticulitis inflammation months after second vaccine) in an 84-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Prostate cancer (He has been taking Xtandi for prostate Cancer for more than a year.). Concomitant products included ENZALUTAMIDE (XTANDI) for Prostate cancer.   On 08-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 15-Aug-2021, the patient experienced DIVERTICULITIS (Diverticulitis inflammation months after second vaccine) (seriousness criteria hospitalization and medically significant). The patient was hospitalized from 15-Aug-2021 to 16-Aug-2021 due to DIVERTICULITIS. The patient was treated with CIPROFLOXACIN HYDROCHLORIDE MONOHYDRATE (CIPRO [CIPROFLOXACIN HYDROCHLORIDE MONOHYDRATE]) for Adverse event, at an unspecified dose and frequency and METRONIDAZOLE BENZOATE (FLAGYL [METRONIDAZOLE BENZOATE]) for Adverse event, at an unspecified dose and frequency. At the time of the report, DIVERTICULITIS (Diverticulitis inflammation months after second vaccine) outcome was unknown.            Action taken with suspect drug was not applicable.  Company Comment - Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded. However, this patient's advanced age and diet (Eat too many seeds) remains a contributory factor.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded. However, this patient's advanced age and diet (Eat too many seeds) remains a contributory factor.
Dose given on 9/28/22 beyond use date was 8/31/22